UTulsa Spinout Auximotus Targets Rehab Robotics for Cerebral Palsy, ALS

Event summary

  • University of Tulsa doctoral student Bradford Kerst founded Auximotus to develop head/neck rehab robotics for cerebral palsy, ALS, and post-stroke patients.
  • Auximotus completed months of pre-patient testing, including failure-mode analysis and therapist consultations.
  • Kerst was selected for the NSF I-Corps program to accelerate commercialization of the technology.
  • The device aims to provide consistent, measurable therapy assistance where human therapists face fatigue and variability challenges.

The big picture

Auximotus enters a growing market for rehabilitation robotics, where consistent, measurable therapy assistance addresses critical gaps in treating cerebral palsy, ALS, and post-stroke patients. The spinout leverages UTulsa's interdisciplinary expertise in robotics and biomechanics, positioning it to compete with established players in the $5B+ global rehab robotics market. Success will depend on clinical validation and therapist adoption of robotic-assisted therapy.

What we're watching

Clinical Validation
How Auximotus' device performs in actual patient trials will determine its market potential.
Commercialization Pace
Whether the NSF I-Corps program accelerates Auximotus' path to FDA approval and commercial launch.
Therapist Adoption
The pace at which physical/occupational therapists integrate robotic assistance into standard protocols.